MARCO ISLAND, Fla. -- Complete Genomics, a leading innovator in genomic sequencing, today unveiled its latest high-performance sequencing solutions at the 2025 Advances in Genome Biology and Technology (AGBT) General Meeting. The newly introduced DNBSEQ-T1+* and DNBSEQ-E25 Flash* are designed to deliver speed, flexibility, and efficiency, empowering researchers with faster, high-quality genomic data. DNBSEQ-T1+: Mid-Throughput Sequencing with Industry-Leading Speed The [...]

OPHiA GENETICS enables institutions across the globe to launch world-class oncology testing BOSTON, MA and ROLLE, Switzerland -- SOPHiA GENETICS (Nasdaq: SOPH), a pioneer in AI healthcare technology and a leader in data-driven medicine, announced a new milestone in the global adoption of its groundbreaking cancer testing applications MSK-ACCESS® powered with SOPHiA DDM™ and MSK-IMPACT® powered with SOPHiA DDM™. Thirty-seven prominent institutions, including top researchers [...]

BOSTON -- Volta Labs, a leading genomics applications company, today announced its four strategic focus areas for 2025 and the expansion of the Callisto App menu to include RNA library prep and single-cell prep, and multi-sequencer capabilities. Key strategic focus areas for Volta Labs in 2025 are: Launching DNA, RNA and single-cell preps for all labs [...]

Vancouver, British Columbia -- Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope Innovations", "Telescope", or the "Company") is a leading developer of advanced technologies and services for the global pharmaceutical and high-value chemical industries. The Company is pleased to provide an update on its Self-Driving Lab ("SDL") technology, which integrates AI, robotics, advanced [...]

Accomplished marketing leader to drive strategic growth and customer-first initiatives NEWARK, Calif. -- Vector Laboratories, a manufacturing partner of reagents and critical components for the development and production of life sciences tools, diagnostics, and clinical-stage biotherapeutics, today announced the appointment of Ashley Scholz as Vice President of Marketing. Ashley brings over 16 years of experience in marketing [...]

Albert’s AI-enabled platform transforms materials science R&D and accelerates chemical innovation OAKLAND, Calif. -- Albert Invent, whose end-to-end R&D platform accelerates chemical innovation in materials science through the application of AI and machine learning, today announced a growth funding round led by J.P. Morgan Private Capital’s Growth Equity Partners, with participation from Coatue and TCV. This [...]

Cambridge, UK – Cresset, a leading provider of integrated in silico solutions for small molecule drug discovery announces the release of its Flare platform V10, bringing enhanced scientific features for both computational and medicinal chemists. The latest release includes significantly enhanced Free Energy Perturbation (FEP) calculations with the inclusion of Absolute FEP, Protein-protein docking, and Protein-Ligand [...]

The QuantumScale platform enables costs of less than 1 cent per cell with workflows across an unprecedented scale SAN DIEGO -- Scale Biosciences (Scale Bio™), a leader in innovative and scalable single cell analysis solutions, today announced the availability of its QuantumScale Single Cell RNA kits, a set of next-generation single cell products which can capture and [...]

Together, these appointments offer a new dimension to IonOpticks’ business development approach. Melbourne: IonOpticks, a world-leading provider of chromatography solutions, today announce two key appointments to strengthen its global operations, enhancing access and support for the LC-MS industry. Erik Verschuuren joins as Head of Global Sales, while Zac Anderson takes the role of Business Development Manager [...]

Commercial launch of UG 100 Solaris which includes new chemistry, software, and simplified workflows for the UG 100 sequencing platform, now with expanded applications support and integration with leading 'omics' technologies Over 50% increase in output to 10 to 12 billion reads per wafer and pricing reduced by 20% to $0.24 per million reads, enabling the $80 genome Increased sensitivity [...]